---

Anaesthetic Management of Bronchiectasis for Right Lower Lobe Lobectomy

Based on Miller's Anesthesia, 10th Edition (9780323935920)

---

1. UNDERSTANDING THE DISEASE: BRONCHIECTASIS

• Airflow obstruction
• Impaired clearance of secretions
• Accumulation of copious, often purulent secretions

1. Soiling of the contralateral (unaffected) lung by infected secretions
2. Lung isolation (essential)
3. One-lung ventilation (OLV) physiology and management
4. Hemostasis risk due to inflamed, hypervascular tissue
5. Sepsis if presenting acutely

---

2. PREOPERATIVE ASSESSMENT

2.1 Pulmonary Function Evaluation

• Spirometry: FEV₁, FVC, FEV₁/FVC
• A predicted postoperative FEV₁ (ppoFEV₁) < 40% of predicted is associated with increased risk
• Diffusing capacity for carbon monoxide (DLCO) also predicts postoperative pulmonary complications

• Stair-climbing or 6-minute walk test
• A patient unable to climb 2 flights of stairs is at significantly elevated risk
• VO₂ max > 15 mL/kg/min predicts good tolerance for lobectomy

• V/Q scan: determines how much of ventilation and perfusion comes from the operative lung
• If the operative (right lower) lung is already poorly perfused/ventilated preoperatively, OLV will be better tolerated
• ABG: baseline PaO₂ and PaCO₂

2.2 Clinical Assessment

• History of hemoptysis (volume, frequency) — massive hemoptysis changes the urgency and approach
• Quantity and character of sputum — daily sputum volume, color, odor
• Current infections — active sepsis contraindicates neuraxial techniques
• Nutritional status — chronic infection leads to cachexia
• Coexisting COPD or reactive airway disease (highly prevalent in this population)
• Medications: bronchodilators, antibiotics, steroids — continue perioperatively
• Review of chest CT by the anesthesiologist personally: assess airway anatomy, extent of disease, tracheal deviation, presence of contralateral disease, mediastinal shift. CT imaging may reveal extrinsic bronchial compression or deviated anatomy that affects lung isolation

2.3 Preoperative Optimization

• Chest physiotherapy and postural drainage to reduce secretion burden
• Appropriate antibiotic therapy to reduce infection
• Bronchodilators to optimize airflow
• Correction of nutritional deficits where time allows
• Cessation of smoking (at least 8 weeks preoperatively reduces complications)

---

3. LUNG ISOLATION — THE CENTRAL CHALLENGE

3.1 Why Lung Isolation is Mandatory

"Anesthetic considerations during surgery for these infective indications include the need for lung isolation to protect uninvolved lung regions from soiling by pus in the infected areas. The risk of soiling occurs if the patient is repositioned for surgery, after induction of anesthesia, before the lung is adequately isolated." — Miller's Anesthesia, Ch. 49

3.2 Choice of Isolation Device: Left-Sided Double-Lumen Tube (DLT)

• The left mainstem bronchus is longer (4–5 cm vs. 1.5–2 cm on the right)
• More margin of safety for positioning
• Right upper lobe bronchus is not at risk of obstruction by the endobronchial cuff

• Distorted left mainstem bronchial anatomy
• Left-sided pneumonectomy or sleeve resection
• Descending thoracic aortic aneurysm
• Left-sided tracheobronchial disruption

3.3 Sizing of the DLT (Table 49.7, Miller's)

3.4 Positioning and Verification

• After intubation in the supine position, confirm placement by auscultation
• Always confirm with fiberoptic bronchoscopy (FOB) — auscultation alone is unreliable
• Through the tracheal lumen: the blue endobronchial cuff should be visible 5–10 mm below the main carina in the left bronchus; identify the right upper lobe bronchus take-off
• Through the endobronchial lumen: confirm patency and visualization of left upper and lower lobe orifices
• After lateral repositioning: recheck position with FOB, as the tube can migrate (especially during turning in a bronchiectasis patient with copious secretions distorting the view)
• Photograph or note the centimeter marking at the teeth for reference

---

4. INDUCTION OF ANAESTHESIA

4.1 Critical Precaution: Isolation BEFORE Repositioning

1. Induce anaesthesia in the supine position
2. Intubate with a left-sided DLT
3. Confirm position with FOB
4. Isolate and suction the right (operative) lung before repositioning
5. Only then turn the patient to the left lateral decubitus position
6. Reconfirm DLT position with FOB after repositioning

4.2 Induction Agents

• Propofol: attenuates airway reflexes, reduces bronchial reactivity — preferred first choice
• Ketamine: bronchodilator — useful if there is significant airway reactivity

• Barbiturates (thiopentone): no bronchodilating effect
• Opioids alone: no bronchodilating effect
• Drugs that release histamine (e.g., atracurium, morphine in high doses) — may worsen bronchospasm

4.3 Airway Management Philosophy

"The principles of anesthetic management are the same as for any asthmatic patient: avoid manipulation of the airway in a lightly anesthetized patient, use bronchodilating anesthetics, and avoid drugs which release histamine." — Miller's Anesthesia, Ch. 49

• Ensure deep anaesthesia before DLT insertion — the added airway manipulation of a DLT is a potent trigger for bronchoconstriction
• Pre-oxygenate thoroughly with 100% O₂
• Consider lidocaine IV or topical (4 mg/kg) to suppress cough and bronchospasm on airway instrumentation

4.4 Muscle Relaxation

• Succinylcholine for rapid sequence if full stomach/septic patient
• Rocuronium (with sugammadex reversal available) — preferred non-depolarizing agent
• Avoid atracurium/mivacurium (histamine release)

---

5. INTRAOPERATIVE MONITORING

"Because surgery is usually performed in the lateral position, monitors are initially placed with the patient in the supine position and have to be rechecked and repositioned after the patient is turned. It is difficult to add additional monitoring, particularly invasive vascular monitoring, after the case is started if complications arise." — Miller's Anesthesia, Ch. 49

---

6. MAINTENANCE OF ANAESTHESIA

6.1 Volatile Agents

• Sevoflurane or isoflurane — preferred volatile agents; both are bronchodilators and attenuate HPV (hypoxic pulmonary vasoconstriction) only modestly at ≤1 MAC
• Sevoflurane may be the most potent bronchodilator of the volatile anesthetics
• Keep volatile at ≤1 MAC during OLV to minimize HPV inhibition and avoid reducing cardiac output

6.2 Total Intravenous Anaesthesia (TIVA)

• Propofol infusion — does not inhibit HPV; preferred in patients where oxygenation is tenuous during OLV
• Combined propofol + remifentanil TIVA is a reliable technique for thoracic surgery

6.3 Nitrous Oxide

• Avoid N₂O in thoracic surgery — risk of enlarging blebs/bullae (though in pure bronchiectasis without bullae this is less critical)
• N₂O speeds non-operative lung collapse but its use is generally not recommended

6.4 Fluid Management

• Restrict fluids: thoracic surgery patients are particularly prone to postoperative pulmonary edema with fluid overload
• Target crystalloid infusion of 1–2 mL/kg/hr during surgery
• Blood products as needed — bronchiectasis surgery can involve significant hemorrhage due to hypervascular, inflamed tissue

---

7. ONE-LUNG VENTILATION (OLV) MANAGEMENT

7.1 Initiating OLV

• Pre-oxygenate the operative lung with 100% O₂ to speed collapse (de-nitrogenation). Nitrogen in the air/O₂ mixture delays collapse significantly
• Perform a recruitment maneuver on the dependent (left) lung to eliminate atelectasis before OLV starts
• Collapse the right lung by clamping the right lumen of the DLT and confirming adequate ventilation of the left lung

7.2 Ventilation Settings During OLV

• Tidal volume: 5–6 mL/kg IBW (avoid large tidal volumes — risk of volutrauma in dependent lung)
• Respiratory rate: adjust to maintain PaCO₂ 40–45 mmHg (permissive mild hypercapnia acceptable)
• PEEP: 5–10 cmH₂O to dependent lung — titrate to maximize compliance while keeping driving pressure ≤15 cmH₂O
• FiO₂: 1.0 initially; reduce if oxygenation is satisfactory
• I:E ratio: 1:2 to 1:2.5

7.3 Prediction of Desaturation During OLV

1. High % ventilation or perfusion to the operative lung on preoperative V/Q scan
2. Poor PaO₂ during two-lung ventilation in the lateral position preoperatively
3. Right-sided thoracotomy (our case — highest risk factor)
4. Normal preoperative spirometry or restrictive disease
5. Supine position during OLV

7.4 Hypoxic Pulmonary Vasoconstriction (HPV)

• HPV is the key protective reflex — vasoconstricts pulmonary vessels in the collapsed (non-ventilated) right lung, diverting blood to the ventilated left lung
• Both volatile anesthetics and vasodilators (nitrates, dobutamine) inhibit HPV
• Maintain volatile anaesthetic at ≤1 MAC to preserve HPV

7.5 Treatment of Hypoxemia During OLV

1. Severe/precipitous desaturation: Resume two-lung ventilation immediately — reinflate operative lung, deflate bronchial cuff
2. Ensure FiO₂ = 1.0
3. Recheck DLT position with FOB — rule out lobar obstruction in ventilated lung (especially important in bronchiectasis where secretions can occlude DLT lumens)
4. Optimize cardiac output — check for IVC compression by surgeon (common during pulmonary resections); treat with inotropes/vasopressors as needed; reduce volatile to ≤1 MAC
5. Recruitment maneuver of ventilated (left) lung: inflate to 20 cmH₂O for 15–20 seconds (will cause transient hypotension and transient further desaturation)
6. Apply PEEP to ventilated lung (5–10 cmH₂O) after recruitment — titrate to maximize compliance
7. Apneic oxygen insufflation: 3 L O₂ via suction catheter into the non-ventilated (right) lumen of DLT — improves PaO₂ without surgical interference
8. CPAP 1–2 cmH₂O to the non-ventilated lung — apply after first recruiting (re-inflating) it; a commercial or improvised CPAP circuit is used. In bronchiectasis patients, CPAP to the operative lung must be used cautiously — it may impede surgical access and the surgeon must be informed
9. Partial ventilation of non-ventilated lung: intermittent IPPV, small tidal volume ventilation
10. Pharmacologic HPV augmentation: almitrine (where available)
11. Mechanical restriction of blood flow to operative lung if possible
12. Venovenous ECMO — last resort

---

8. SPECIAL CONSIDERATIONS IN BRONCHIECTASIS

8.1 Secretion Management

• The DLT must be suctioned frequently throughout the case — bronchiectasis generates copious infected secretions that can obstruct the DLT lumens
• FOB should be available throughout the procedure for repeated position checks and targeted suctioning
• Secretions contaminating the tracheal lumen can cause obstruction or soiling of the left lung — vigilance is paramount

8.2 Septic Patient

• If the patient presents with active sepsis: placement of a thoracic epidural catheter is NOT recommended (risk of epidural abscess)
• Septic patients have altered pharmacodynamics and hemodynamics
• Early vasopressor support may be needed (norepinephrine infusion via central line)

8.3 Hemorrhage Risk

"Due to the inflammation, surgery is technically more difficult and there is a greater risk of massive hemorrhage." — Miller's Anesthesia, Ch. 49

• Large-bore IV access ×2 or central line with large lumen
• Type and cross-match for packed red cells
• Have vasopressors and blood products readily available
• Cell salvage may be considered (though infected field limits its use)

8.4 Hemoptysis

• If the indication is hemoptysis, the risk of contaminating the contralateral lung is highest
• Lung isolation must be secured before any patient movement
• If massive hemoptysis: the DLT also provides the ability to isolate and tamponade the bleeding lung

---

9. POSITIONING

• Left lateral decubitus position (right side up for right-sided surgery)
• Recheck DLT position with FOB after final positioning
• Axillary roll under the dependent chest wall
• Dependent arm extended, upper arm supported to avoid brachial plexus injury
• Ensure all pressure points are padded
• Head in neutral position
• Lower limb in dependent position with padding between knees

---

10. POSTOPERATIVE ANALGESIA

10.1 Thoracic Epidural Analgesia (TEA)

• Gold standard for post-thoracotomy pain
• Placed at T4–T6 level; local anaesthetic + opioid combination (e.g., bupivacaine 0.125% + fentanyl 2 mcg/mL or hydromorphone)
• Benefits: superior analgesia, reduced atelectasis, reduced opioid requirements, possible cardiac benefit, may reduce risk of chronic post-thoracotomy pain
• Contraindication: active sepsis/bacteremia — do NOT place epidural if patient is septic

10.2 Paravertebral Block (PVB)

• Excellent alternative to epidural when epidural is contraindicated (e.g., sepsis) or technically difficult
• Provides ipsilateral multi-dermatome analgesia
• Can be placed preoperatively or intraoperatively under direct vision by the surgeon
• Fewer side effects than epidural (no hypotension, urinary retention)

10.3 Intercostal Nerve Blocks

• Useful supplement; limited duration unless a catheter technique is used

10.4 Multimodal Analgesia

• Paracetamol (acetaminophen) IV
• NSAIDs (unless contraindicated by renal function, platelet function)
• Opioids (morphine or oxycodone PCA) as rescue

---

11. EXTUBATION AND POSTOPERATIVE CARE

11.1 Extubation Criteria

"Extubation in the operating room is encouraged if the patient meets standard criteria for extubation." — Miller's Anesthesia, Ch. 49

• Awake, cooperative, following commands
• Adequate reversal of neuromuscular blockade (TOF ratio >0.9)
• Adequate respiratory effort (VC >15 mL/kg, NIF >−25 cmH₂O)
• SpO₂ ≥95% on FiO₂ ≤0.4
• Temperature and hemodynamic stability
• Controlled pain

11.2 DLT Exchange

• Convert the DLT to a standard single-lumen ETT if the patient requires postoperative ventilation — DLTs are not designed for long-term ventilation
• Use an airway exchange catheter (Cook AEC) for safe tube exchange

11.3 Postoperative Care

• HDU or ICU admission for at least 24 hours
• Aggressive chest physiotherapy and airway suctioning — bronchiectasis patients have persistent secretion burden
• Early mobilization
• Regular chest X-ray to detect atelectasis, pneumothorax, haemothorax
• Monitor drain output (chest drain placed by surgeon intraoperatively)
• Incentive spirometry
• Watch for bronchopleural fistula (persistent air leak, purulent drainage)

---

12. COMPLICATIONS SPECIFIC TO THIS CASE

---

SUMMARY ALGORITHM

PREOP: PFTs + V/Q scan + CT airway review + optimize secretions
          ↓
INDUCTION: Supine → Propofol/Ketamine → Left-sided DLT
          ↓
CONFIRM: FOB verification of DLT → Suction right lung → Isolate
          ↓
POSITION: Left lateral decubitus → Re-confirm DLT with FOB
          ↓
OLV: 100% O₂ pre-denitrogenation → Tidal vol 5-6 mL/kg → PEEP 5–10 cmH₂O
     Volatile ≤1 MAC → Frequent DLT suctioning
          ↓
HYPOXIA: Box 49.12 stepwise → CPAP to non-ventilated / PEEP to ventilated
          ↓
EXTUBATION: OT extubation if criteria met → TEA or PVB analgesia
          ↓
POSTOP: ICU/HDU → Chest physiotherapy → Monitor for BPF

---

• Miller's Anesthesia, 2-Volume Set, 10th Edition — Chapter 49: Anesthesia for Thoracic Surgery
  • Section: Bronchiectasis/Lung Abscess/Empyema (p. 7282–7285)
  • Section: Anesthetic Management (p. 7285)
  • Section: Double-Lumen Tubes and Positioning (pp. 7148–7155)
  • Section: One-Lung Ventilation — Management, Prediction of Desaturation, Treatment of Hypoxemia (pp. 7121–7217)
  • Box 49.7: Risk Factors for Desaturation During OLV
  • Box 49.8: Indications for Right-Sided DLT
  • Box 49.12: Therapies for Desaturation During OLV
  • Table 49.7: DLT Size Selection

---

1. Pathophysiology — Starling equation, stages of pulmonary edema (interstitial → alveolar), mechanisms (hydrostatic vs. permeability vs. lymphatic)
2. Classification — All 6 types relevant to anaesthesia:
   • Cardiogenic (volume overload, LV failure)
   • ARDS (noncardiogenic permeability)
   • TRALI (transfusion-related, with full diagnostic criteria)
   • TACO (transfusion-associated circulatory overload — distinguished from TRALI)
   • Postobstructive/Negative Pressure Pulmonary Edema (NPPE) — particularly important perioperatively after laryngospasm
   • Re-expansion and neurogenic types
3. Preoperative assessment — History, examination, investigations (CXR, echo, BNP, ABG, lung ultrasound, EVLW)
4. Intraoperative management — Monitoring (PAC, PiCCO, TEE, lung USS), anaesthetic agent selection, lung-protective ventilation strategy with PEEP physiology, fluid restriction, pharmacotherapy (furosemide, GTN, dobutamine, norepinephrine), stepwise response to acute intraoperative onset
5. Differential diagnosis table — Quick bedside comparison of all perioperative forms

---

Six Core Respiratory Topics — Miller's Anesthesia, 10th Edition

---

1. HYPOXIA

1.1 Definition

1.2 Classification — The Four Types

1.3 Causes of Hypoxic Hypoxia (Five Mechanisms)

• Reduced alveolar ventilation → CO₂ retention → PAO₂ falls (governed by alveolar gas equation)
• PAO₂ = FiO₂(PB − 47) − PaCO₂/0.8
• Causes: opioids, residual anaesthetics, neuromuscular blockade, obesity, pain splinting
• Anaesthetic relevance: the most common cause of hypoxia in the PACU

• Most common cause of intraoperative hypoxia
• Low V/Q areas act as shunt equivalents — blood leaves without being oxygenated
• High V/Q areas act as dead space — wasted ventilation
• Causes: atelectasis (universal in anaesthesia), pneumonia, pulmonary embolism, bronchospasm, one-lung ventilation

"Mild to moderate hypoxemia (SaO₂ 85%–90%) is common [during anaesthesia] and lasts from seconds to minutes; sometimes it is severe, and approximately 20% of patients may suffer from SaO₂ less than 81% for up to 5 minutes. Indeed, greater than 50% of claims in anaesthesia-related deaths relate to hypoxemia during anesthesia." — Miller's Anesthesia, Ch. 12

• Blood bypasses ventilated alveoli completely
• Does not respond to supplemental O₂ (unlike V/Q mismatch which does)
• Causes: atelectasis, consolidation, pulmonary oedema, ARDS, intracardiac shunt (PFO)

• Thickened alveolar-capillary membrane limits O₂ transfer
• Occurs with exercise (reduced transit time) or disease (fibrosis, interstitial lung disease)
• Usually mild at rest; significant exercise hypoxaemia

• Equipment failure, pipeline hypoxia, high altitude

1.4 Diffusion Hypoxia (Fink Effect) — Anaesthetic-Specific

"Diffusion hypoxia is a sequela of rapid outgassing from the tissues of patients anesthetized with N₂O. During the initial 5–10 minutes after discontinuation of anaesthesia, the flow of N₂O from blood into the alveoli can be several litres per minute, resulting in dilution of alveolar oxygen." — Miller's Anesthesia, Ch. 18

• N₂O also reduces alveolar PCO₂ → blunts respiratory drive
• Combined with respiratory depression from residual anaesthetic → hypoxaemia
• Prevention: 100% O₂ for 5–10 minutes after discontinuing N₂O

1.5 Signs and Symptoms of Hypoxia

"Initially, hypoxemia may not result in any EEG changes because the brain can increase cerebral blood flow to compensate. When the hypoxemia becomes severe enough… 'Slowing' of the EEG during hypoxia is a nonspecific global effect. Fast frequencies are lost, and low frequencies dominate. Eventually, the EEG is abolished as the brain shuts down electric activity and diverts all oxygen delivered to maintenance of cellular integrity." — Miller's Anesthesia, Ch. 39

1.6 Physiological Responses to Hypoxia

From Ch. 70 (High Altitude Medicine), acclimatization responses apply to hypoxia in general:

• Peripheral chemoreceptors (carotid/aortic bodies) stimulated → hyperventilation (hypoxic ventilatory response — HVR)
• Sympathetic activation → tachycardia, ↑ cardiac output, vasoconstriction
• Erythropoietin (EPO) release → ↑ RBC production, ↑ haemoglobin
• Hypoxic pulmonary vasoconstriction (HPV) → diverts blood from poorly ventilated lung areas
• 2,3-DPG increases → right-shifts ODC → facilitates O₂ unloading at tissues

1.7 Treatment of Hypoxia

---

2. OXYGEN–HAEMOGLOBIN DISSOCIATION CURVE (ODC)

2.1 The Curve — Shape and Significance

2.2 The Upper (Flat) Part of the Curve

• Between PaO₂ 60–100 mmHg
• Hb remains near-fully saturated despite large changes in PaO₂
• Protective plateau: even if PaO₂ falls from 100 → 60 mmHg, SaO₂ only falls from 97.5% → 90%
• Ensures O₂ loading in the lungs remains adequate across a range of PAO₂

2.3 The Lower (Steep) Part of the Curve

• Below PaO₂ 60 mmHg
• Small further falls in PaO₂ produce large falls in SaO₂
• Facilitates O₂ unloading at the tissues: tissues consuming O₂ drop PO₂ from 40 → 20 mmHg → large amount of O₂ released per mmHg change

2.4 The P₅₀

• Increased P₅₀ = right shift = lower O₂ affinity = more O₂ released to tissues (beneficial at tissues)
• Decreased P₅₀ = left shift = higher O₂ affinity = less O₂ released to tissues (beneficial for loading in hypoxic lungs)

2.5 Factors Shifting the ODC

RIGHT SHIFT (↑ P₅₀ → ↓ Hb-O₂ affinity → facilitates O₂ UNLOADING)

LEFT SHIFT (↓ P₅₀ → ↑ Hb-O₂ affinity → facilitates O₂ LOADING)

2.6 The Bohr Effect

The Bohr effect describes the rightward shift of the ODC in the presence of CO₂ and acidosis (↑ H⁺). At the tissues, metabolically active cells produce CO₂ and lactic acid → local acidosis → Hb affinity for O₂ decreases → O₂ released more readily. In the lungs, CO₂ is eliminated → local alkalosis → Hb affinity increases → O₂ loaded more readily.

2.7 Anaesthetic Implications

• Hypothermia during CPB: left-shifts ODC → Hb holds on to O₂ → less O₂ delivered. Must target adequate PaO₂ to compensate.
• Alkalosis from hyperventilation (during controlled ventilation): left shift → potential tissue hypoxia despite adequate SaO₂
• Stored blood (low 2,3-DPG after 2 weeks storage): left shift → transfused blood initially has ↑ Hb-O₂ affinity, reduced O₂ delivery. Returns to normal within 24 hours
• CO poisoning: SpO₂ by pulse oximetry is falsely normal — carboxyhaemoglobin is read as oxyhaemoglobin. PaO₂ may be normal but CaO₂ is drastically reduced. Use CO-oximetry.
• MetHb: also falsely elevates SpO₂ readings

2.8 Oxygen Content Equation

• Hb 15 g/dL, SaO₂ 98%, PaO₂ 100: CaO₂ ≈ 19.7 + 0.3 = 20 mL/dL
• The dissolved component (×0.003) is minimal at atmospheric pressure but significant at hyperbaric pressures

• Normal DO₂ ≈ 1000 mL/min
• Normal VO₂ ≈ 250 mL/min
• O₂ extraction ratio = VO₂/DO₂ ≈ 25%

---

3. FLOW–VOLUME LOOPS

3.1 What They Are

"Spirometry can display flow–volume loops… The characteristic shape of some respiratory flow–volume loops can help diagnose various respiratory diseases." — Miller's Anesthesia, Ch. 67

3.2 Components of a Normal Flow–Volume Loop

• Begins at TLC with a sharp peak expiratory flow rate (PEFR)
• Rapidly rises to PEFR then gradually declines as lung volume decreases toward RV
• The declining portion is effort-independent — determined by elastic recoil and airway resistance, not patient effort
• Ends at RV

• From RV to TLC
• Rounded curve; lower peak flow than expiration
• Effort-dependent throughout — determined by patient effort
• Peak inspiratory flow (PIF) < peak expiratory flow in normal subjects

3.3 Patterns of Abnormal Flow–Volume Loops

A. Obstructive Pattern (e.g., COPD, Asthma)

• FEV₁/FVC <70%
• Characteristic "scooped-out" (concave) expiratory limb — airway collapse during forced expiration reduces flow disproportionately at lower lung volumes
• TLC normal or increased (air trapping)
• PEFR may be preserved but mid-expiratory flow (FEF 25–75%) is markedly reduced
• Auto-PEEP visible on ventilator FVL as a persistent end-expiratory flow that does not return to zero

"There is a classic scooped-out appearance to the exhalation portion of a flow–volume curve with obstructive lung disease." — Miller's Anesthesia, Ch. 67

B. Restrictive Pattern (e.g., Pulmonary Fibrosis, Neuromuscular Disease)

• FEV₁/FVC preserved (>70%) but FVC reduced
• Both inspiratory and expiratory flows reduced proportionally
• Loop is narrow but normally shaped — a "small normal loop"
• TLC and RV both reduced

C. Variable Intrathoracic Obstruction (e.g., Tracheomalacia, Intrathoracic Tumour)

• Expiratory limb flattened (plateau) — during forced expiration, positive pleural pressure compresses the intrathoracic trachea at the site of lesion
• Inspiratory limb normal — negative intrathoracic pressure during inspiration stents the airway open
• Classic pattern: expiratory plateau with normal inspiratory curve

D. Variable Extrathoracic Obstruction (e.g., Vocal Cord Paralysis, Subglottic Stenosis)

• Inspiratory limb flattened — during forced inspiration, negative pressure in the trachea below the glottis collapses a flaccid extrathoracic trachea
• Expiratory limb normal — positive subglottic pressure during expiration stents airway open

E. Fixed Obstruction (e.g., Tracheal Stenosis, Rigid Goitre)

• Both inspiratory AND expiratory limbs are flattened — the lesion is rigid and unyielding regardless of transmural pressure
• Classic box-shaped loop (plateau on both sides)
• Seen with bilateral vocal cord paralysis, rigid tracheal stenosis

"Spirometry can also help identify variable intrathoracic or fixed (intra- or extrathoracic) airway obstruction from the shape of the forced expired flow–volume curve (Fig. 12.22)." — Miller's Anesthesia, Ch. 12

3.4 Anaesthetic Implications of Flow–Volume Loops

• Mediastinal masses: FVL should be performed preoperatively; exacerbation of a variable intrathoracic obstructive pattern (expiratory plateau) on supine FVL is a warning of dynamic airway compression under GA

"Children with tracheobronchial compression greater than 50% on CT scan cannot be safely given general anaesthesia. Flow–volume loops, specifically the exacerbation of a variable intrathoracic obstructive pattern (expiratory plateau), confirm the risk." — Miller's Anesthesia, Ch. 49

• Intraoperative FVL monitoring (continuous spirometry during OLV):
  • Persistent end-expiratory flow on FVL = auto-PEEP development
  • Sudden loss of tidal volume on FVL = DLT migration or circuit disconnection
  • Air leak quantified by difference between inspiratory and expiratory VT

3.5 FVL vs Pressure–Volume Loops

• PV loops during mechanical ventilation: identify lower inflection point (begin PEEP above this), upper inflection point (reduce tidal volume to avoid overdistension — "bird's beak" appearance)
• Used to optimize PEEP and tidal volume in ARDS

---

4. WORK OF BREATHING

4.1 Definition and Formula

"The work of breathing (W) represents the energy required to inflate or deflate the lungs, or chest wall, or both, by a specified volume." — Miller's Anesthesia, Ch. 37

4.2 Components of Work of Breathing

• Work done against the elastic recoil of the lungs and chest wall
• Represented by the triangular area under the static pressure-volume relationship
• Stored during inspiration; recovered during passive expiration (does not contribute to total WOB in passive expiration)
• Increased in: pulmonary fibrosis (↑ elastic recoil), pulmonary oedema, ARDS, obesity, abdominal distension

• Work done to overcome airway resistance (turbulent and laminar flow) and lung tissue viscoelasticity
• Dissipated as heat — cannot be recovered
• Represented by the area between the actual P-V curve and the static compliance line
• Increased in: COPD, asthma, bronchospasm, secretions, narrow airway devices (small ETT)

"Respiratory work is further divided into elastic work (required to overcome the recoil of the lung) and resistive work (required to overcome airway flow resistance and viscoelastic resistance of pulmonary tissues). The work of breathing is usually derived from transpulmonary pressure–volume curves." — Miller's Anesthesia, Ch. 19

4.3 Mechanical Power

"Mechanical power, as an index of the rate of energy dissipation, can be used to assess the risk of developing ventilator-induced lung injury (VILI), particularly with changes in transpulmonary pressure during ventilation." — Miller's Anesthesia, Ch. 37

• High mechanical power → excessive energy transfer to the lung per unit time → risk of VILI
• Relevant to ventilator settings in ARDS — high respiratory rate, high driving pressure, and high PEEP all contribute to mechanical power

4.4 Energetically Optimal Breathing Frequency

"For a given VT, W varies as a function of respiratory rate and, in most cases, achieves a minimum at a specified frequency. This frequency is termed the energetically optimum breathing frequency, as this is the rate at which energy expenditure is minimised."

• Normal individuals: ~15 breaths/min
• Emphysema: decreased elastic recoil → lower optimal frequency (breathe slowly and deeply)
• Restrictive disease: increased elastic recoil → higher optimal frequency (breathe fast and shallowly)
• Neonates: high RR is energetically optimal due to compliant chest wall

4.5 Factors Increasing Work of Breathing

4.6 Anaesthetic Effects on Work of Breathing

"In general, volatile anesthetics decrease the work of breathing in adults and children… Sevoflurane reduces pulmonary compliance at the lung periphery rather than at the airway level, thereby increasing viscoelastic and elastic pressures in the lung. In a murine model of chronic asthma, sevoflurane significantly decreased resistance in central and distal airways and lowered resistance in the lung periphery." — Miller's Anesthesia, Ch. 19

• All volatile agents (except desflurane at standard doses) reduce respiratory system resistance by ~15% at 1 MAC, reducing WOB
• Desflurane: does NOT reduce bronchomotor tone; can actually increase WOB via airway irritation
• Mechanical ventilation takes over WOB from the patient entirely — WOB from the patient = 0 during controlled ventilation

4.7 Reduction of Work of Breathing (Clinical Strategies)

From Miller's Ch. 9 (reduction of WOB section):

• Positive pressure ventilation (PPV): takes over resistive and elastic WOB
• CPAP/PEEP: reduces WOB by preventing cyclic alveolar collapse and re-recruitment; shifts PV curve to more compliant region
• Bronchodilators: reduce resistive WOB
• Positioning (head-up/semi-recumbent): reduces abdominal splinting of diaphragm
• Extubation to CPAP/NIV: bridges the transition to independent breathing
• Adequate analgesia: prevents splinting from pain (especially after thoracic/upper abdominal surgery)

---

5. INCENTIVE SPIROMETRY

5.1 Definition and Rationale

• Prevent and treat postoperative atelectasis
• Restore functional residual capacity (FRC) after surgery
• Improve mucociliary clearance
• Strengthen respiratory muscles

5.2 Physiological Basis

• Pain causes splinting → shallow breathing → low VT → atelectasis
• Residual anaesthetics/opioids → reduced respiratory effort
• Supine position → ↓ FRC, diaphragm elevation → dependent atelectasis
• Neuromuscular weakness → ↓ inspiratory force

"The atelectasis that develops intraoperatively may last for some days after surgery and may be a cause of postoperative pulmonary complications." — Miller's Anesthesia, Ch. 12

5.3 Types of Incentive Spirometers

5.4 Technique of Incentive Spirometry

1. Patient assumes upright or semi-upright position (maximises FRC, diaphragm excursion)
2. Exhale normally to FRC
3. Place mouthpiece in mouth — seal lips
4. Inhale slowly and deeply to achieve target volume (TLC)
5. Hold breath for 3–5 seconds — allows recruited alveoli to stabilise (like a sustained sigh)
6. Exhale passively
7. Repeat 10 times per hour while awake

5.5 Clinical Indications

• Post-thoracotomy / lobectomy / pneumonectomy
• Post-upper abdominal surgery (gastrectomy, hepatectomy, oesophagectomy)
• COPD patients perioperatively
• Neuromuscular disease (Myasthenia Gravis, Guillain-Barré)
• Obesity — reduced FRC
• ICU ventilator weaning

5.6 Goals and Monitoring

• Target volume should be set at ≥80% of predicted inspiratory capacity or above pre-illness baseline
• Monitor SpO₂ during sessions
• Combine with chest physiotherapy, airway clearance techniques, early mobilisation, and adequate analgesia for best effect
• Can be used from POD 0 if patient is awake and cooperative

5.7 Limitations

• Requires patient cooperation and understanding — not useful in confused or sedated patients
• Does not address secretion clearance directly (combine with coughing, huffing, nebulisation)
• Evidence for routine universal use is mixed — most benefit in high-risk patients (COPD, obesity, thoracic/upper abdominal surgery)

---

6. THE OXYGEN CASCADE

6.1 Concept

6.2 The Steps of the Oxygen Cascade

ATMOSPHERE → TRACHEA → ALVEOLUS → ARTERIAL BLOOD → CAPILLARY BLOOD → TISSUE CELL → MITOCHONDRIA

6.3 Key Equations Along the Cascade

• A-a gradient = PAO₂ − PaO₂
• Normal = 5–15 mmHg (increases with age: approx. age/4)
• Causes of raised A-a gradient:
  • V/Q mismatch (most common)
  • Intrapulmonary shunt
  • Diffusion impairment
  • Hypoventilation does NOT raise the A-a gradient (both PAO₂ and PaO₂ fall equally)

• Mixed venous PO₂ (PvO₂) reflects DO₂ / VO₂ balance
• Normal PvO₂ = 40 mmHg, SvO₂ = 75%
• SvO₂ <60% indicates increased O₂ extraction (↑ metabolic demand or ↓ DO₂)
• SvO₂ >80% in sepsis = distributive defect — cells cannot extract O₂

6.4 The Cascade Under Anaesthesia

"Anesthesia impairs pulmonary function, whether the patient is breathing spontaneously or is receiving mechanical ventilation. Impaired oxygenation of blood occurs in most subjects who are anaesthetized, and this is why supplemental O₂ (FiO₂ usually 0.3–0.5) is almost invariably used." — Miller's Anesthesia, Ch. 12

6.5 The A-a Gradient in Clinical Practice

• A patient breathing 100% O₂ with PaO₂ of 400 mmHg has a different clinical situation than one with PaO₂ of 400 mmHg breathing 40% O₂
• PaO₂/FiO₂ ratio (P:F ratio) is a practical bedside index:
  • Normal: >400–500
  • Mild ARDS: 200–300
  • Moderate ARDS: 100–200
  • Severe ARDS: <100

• Normal <0.4

• 1.0 indicates severe respiratory failure

6.6 Hyperbaric Oxygen and the Cascade

"At an elevated PaO₂ in the range of 1000–2000 mmHg, significant quantities of O₂ may exist in dissolved form… Increased PaO₂ has at least five pharmacologic effects: increased blood O₂ content, vasoconstriction, antibacterial action, inhibition of endothelial neutrophil adhesion, and anti-inflammatory effect." — Miller's Anesthesia, Ch. 71

• PaO₂ ~2100 mmHg
• Dissolved O₂ alone (×0.003) = 6.3 mL/dL — sufficient for resting metabolic needs without haemoglobin
• Cascade is "widened" but tissue PO₂ increases dramatically

---

SUMMARY TABLE — Key Numbers to Remember

---

• Chapter 12: Respiratory Physiology During Anaesthesia — Spirometry, FVL, Atelectasis, A-a gradient (pp. 1295–1322)
• Chapter 18: Inhaled Anaesthetics — Diffusion Hypoxia (p. 1977)
• Chapter 19: Inhaled Anaesthetics on Airway — Work of Breathing, bronchomotor effects (pp. 2074–2076)
• Chapter 28/70: High Altitude Medicine — Physiological Responses to Hypoxia (pp. 10262–10265)
• Chapter 37: Respiratory Monitoring — Work of Breathing and Mechanical Power (pp. 5535–5540)
• Chapter 39: Neurophysiological Monitoring — EEG changes in Hypoxia (pp. 5297–5298)
• Chapter 49: Thoracic Anaesthesia — FVL during OLV, Continuous Spirometry (pp. 7130–7132)
• Chapter 67/71: Pediatric/Hyperbaric — FVL in respiratory monitoring; O₂ cascade at pressure (pp. 11319–11321)

---

• GINA definition, epidemiology, cellular pathophysiology (mast cells, eosinophils, leukotrienes)
• Severity classification, physiological consequences
• Preoperative history (the "9-question Miller's checklist"), examination, investigations
• Optimisation — continue all medications, SABA pre-op, stress-dose steroids
• Laparoscopic-specific: CO₂ pneumoperitoneum effects on FRC, airway pressures, compliance, atelectasis
• Airway device choice (LMA vs. ETT), premedication
• Induction: Propofol or Ketamine (not thiopentone)
• Maintenance: Sevoflurane (most potent bronchodilator); avoid Desflurane
• Ventilation: slow RR, prolonged I:E ratio (1:3–1:4), low PEEP, monitor auto-PEEP
• Drug avoidance table (NSAIDs, atracurium, desflurane, β-blockers, morphine, neostigmine alone)
• Extubation under deep anaesthesia

• Definition, 3-stage pathophysiology, clinical severity scoring table
• The critical sign: normal PaCO₂ during hyperventilation = impending failure

• Stepwise drug therapy: O₂ → continuous albuterol → IV steroids → IV MgSO₄ → heliox → ketamine
• Ketamine: the anaesthetist's pivotal drug — doses for both sedation and RSI
• RSI protocol (Ketamine + Midazolam + Rocuronium + Glycopyrrolate)
• Mechanical ventilation: permissive hypercapnia, slow RR (6–10/min), I:E 1:4, low PEEP
• Volatile anaesthetics (sevoflurane/isoflurane) for refractory cases
• VV-ECMO as last resort

• Recognition, DOPE differential diagnosis, 12-step treatment ladder
• Postoperative care checklist

• Pro vs. free plan differences
• Whether credits are required
• What features are unlocked at each tier

• The platform's official website or FAQ
• Their pricing/plans page
• Reaching out to their support team directly

---

• Physiology of CO₂ pneumoperitoneum (respiratory, cardiovascular, renal, endocrine effects) with the important paradox of less shunt despite more atelectasis
• Positioning-specific concerns: Trendelenburg (laryngeal oedema, ICP/IOP rise), Reverse Trendelenburg, lateral decubitus
• Deep NMB to reduce IAP from 15 → 10 mmHg
• LMA vs. ETT selection, ventilation strategy (↑ MV by 10-25%), PONV prophylaxis
• Recognition and management of intraoperative emergencies (vagal arrest, CO₂ embolism, subcutaneous emphysema, pneumothorax)

• All 5 hepatitis types; HCV causing 90% of post-transfusion hepatitis
• Elective surgery mortality in acute hepatitis: up to 10% (emergency: 50%)
• Drug pharmacokinetics in liver disease; halothane hepatitis; cisatracurium preference
• Child-Pugh scoring and MELD score for perioperative risk stratification

• All three types; systemic consequences across all organ systems
• IV Vitamin K response testing as the pivotal preoperative test
• Cisatracurium, fentanyl/remifentanil, sevoflurane as preferred drugs
• Mannitol for renal protection

• Thoracic epidural as cornerstone (T6–T8; bupivacaine + fentanyl)
• Cisatracurium; restrictive + goal-directed fluids; TEG/ROTEM-guided coagulation
• Glycaemic control (monitoring every 30–60 min); temperature management; ERAS protocol
• ICU post-op; drain amylase day 1–3 for pancreatic fistula

• Highest perioperative AKI risk of any hepatobiliary condition — detailed multifactorial mechanism
• Mannitol + oral lactulose + hydration for renal protection
• Bradycardia from bile salts (atropine at induction); RSI; avoid NSAIDs/morphine/atracurium
• EBD (ERCP stenting) indications preoperatively